OverviewSuggest Edit

Organigram is a producer of medical cannabis and cannabis-derived products. The company offers indoor-grown cannabis for patients and adult recreational consumers. Its portfolio of legal adult use recreational cannabis brands includes Edison Cannabis, ANKR Organics, and Trailblazer.

TypePublic
Founded2013
HQMoncton, CA
Websiteorganigram.ca

Latest Updates

Employees (est.) (Aug 2019)770(+117%)
Revenue (FY, 2019)C$80.4 M(+547%)
Share Price (Feb 2021)C$3.8 (-9%)
Cybersecurity ratingBMore

Key People/Management at Organigram

Gregory Engel

Gregory Engel

Chief Executive Officer, Director
Amy Schwalm

Amy Schwalm

Vice President, Investor Relations
Paolo de Luca

Paolo de Luca

Chief Strategy Officer
Tim Emberg

Tim Emberg

Senior Vice President, Sales and Commercial Operations
Helen Martin

Helen Martin

Senior Vice President, Strategic and Legal Affairs
Derrick West

Derrick West

Chief Financial Officer
Show more

Organigram Office Locations

Organigram has offices in Moncton and Toronto
Moncton, CA (HQ)
35 English Dr
Toronto, CA
Bay Adelaide Centre, 333 Bay St #1250
Show all (2)

Organigram Financials and Metrics

Organigram Revenue

Embed Graph
View revenue for all periods
Organigram's revenue was reported to be C$80.41 m in FY, 2019 which is a 547% increase from the previous period.
CAD

Revenue (Q1, 2020)

25.2m

Gross profit (Q1, 2020)

11.2m

Gross profit margin (Q1, 2020), %

44.5%

Net income (Q1, 2020)

(863.0k)

EBIT (Q1, 2020)

154.0k

Market capitalization (25-Feb-2021)

891.5m

Closing stock price (25-Feb-2021)

3.8

Cash (30-Nov-2019)

34.0m

EV

942.0m
Organigram's current market capitalization is C$891.5 m.
Annual
CADFY, 2017FY, 2018FY, 2019

Revenue

5.4m12.4m80.4m

Revenue growth, %

131%547%

Cost of goods sold

8.7m4.7m31.9m

Gross profit

(3.3m)7.8m48.5m
Quarterly
CADQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Revenue

2.2m(581.2k)1.9m2.7m3.7m3.7m12.4m26.9m24.8m25.2m

Cost of goods sold

1.5m3.4m2.7m1.1m1.4m1.3m2.9m19.0m24.9m14.0m

Gross profit

762.9k(4.0m)(757.4k)1.6m2.3m2.4m9.5m8.0m(179.0k)11.2m

Gross profit Margin, %

34%684%(40%)60%63%65%77%30%(1%)45%
Annual
CADFY, 2017FY, 2018FY, 2019

Cash

55.1m55.1m47.6m

Accounts Receivable

793.0k793.0k11.9m

Prepaid Expenses

3.4m3.4m17.1m

Inventories

45.0m45.0m93.1m
Quarterly
CADQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Cash

7.6m1.3m2.7m7.6m53.7m31.6m30.2m12.5m47.2m34.0m

Accounts Receivable

514.0k1.1m541.6k514.0k995.0k795.0k11.2m21.7m14.6m13.5m

Prepaid Expenses

1.8m473.6k847.3k1.8m1.7m1.3m1.0m1.4m11.9m11.6m

Inventories

4.2m2.7m2.0m4.2m8.7m17.6m91.4m95.1m94.2m101.9m
Annual
CADFY, 2017FY, 2018FY, 2019

Net Income

(10.8m)22.1m(9.5m)

Depreciation and Amortization

1.6m3.5m8.9m

Inventories

1.3m(42.3m)(47.2m)

Accounts Payable

671.0k4.0m10.6m
Quarterly
CADQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Net Income

(1.4m)(6.5m)(8.9m)(1.4m)(324.1k)2.5m29.5m23.1m13.0m(863.0k)

Depreciation and Amortization

480.1k665.8k1.0m480.1k1.1m2.0m1.7m3.5m5.7m3.4m

Inventories

(1.6m)1.3m1.9m(1.6m)(6.1m)(14.9m)(46.5m)(50.2m)(49.2m)(8.8m)

Accounts Payable

513.5k2.7m1.5m513.5k5.5m2.4m(2.9m)(5.2m)3.2m(10.9m)
CADQ1, 2017

Financial Leverage

1.1 x
Show all financial metrics

Organigram Operating Metrics

Organigram's Patients was reported to be 18.1 k in Q1, 2020.
Q1, 2017Q2, 2017Q3, 2017Q4, 2017Q1, 2018Q2, 2018Q3, 2018Q4, 2018Q1, 2019Q2, 2019Q3, 2019Q4, 2019Q1, 2020

Brands

5 5 5 4 4 3

Cannabis Harvested, kilograms

8.32 k6.05 k7.43 k12.76 k

Cannabis Sold, kilogram and kilogram equivalents

4.99 k4.62 k2.90 k5.50 k

Patients

4 k4.04 k5.51 k7.40 k10.73 k12.96 k15.32 k15.73 k13.51 k14.88 k17 k17.20 k18.13 k
Show all operating metrics

Organigram Acquisitions / Subsidiaries

Company NameDateDeal Size
Organigram Inc.

Organigram Cybersecurity Score

Cybersecurity ratingPremium dataset

B

88/100

SecurityScorecard logo

Organigram Online and Social Media Presence

Embed Graph

Organigram News and Updates

CEO’s of OrganiGram, Icanic Brands, Red Light Holland, and Sundial Growers, Driving New Growth Opportunities in Cannabis and Psychedelics

NEW YORK, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: OrganiGram Holdings (NASDAQ: OGI), Icanic Brands (OTC: ICNAF) (CSE: ICAN), Red Light Holland (OTC: TRUFF) (CSE…

OrganiGram stock drops after cannabis company reports wider loss, revenue miss

The U.S.-listed shares of OrganiGram Holdings Inc. dropped 2.3% in premarket trading, as the Canada-based cannabis company reported a much wider fiscal first-quarter net loss and net revenue that fell more than forecast, while adult-use recreational cannabis revenue jumped. The net loss for the qua…

Cannabis company Organigram posts wider-than-expected loss as revenue falls short in Q4

Canadian cannabis company Organigram Inc. said Tuesday it had a net loss of C$89.9 million ($66.6 million), or 51 cents a share, in its fiscal third quarter to May 31, wider than the net loss of C$10.2 million, or 7 cents a share, posted in the year-earlier period. Revenue net of excise taxes fell …

Canadian cannabis company OrganiGram loss widens in latest quarter as revenue falls short of estimates

Canadian cannabis company OrganiGram Holdings Inc. said Tuesday it had a net loss of C$6.8 million ($4.9 million), or 41 cents a share, in its fiscal second quarter to Feb. 29, wider than the loss of C$6.4 million, or 49 cents a share, posted in the year-earlier period. Revenue fell to C$23.2 milli…

OrganiGram CFO De Luca to be chief strategy officer, board member West to be CFO

OrganiGram Holdings Inc. said Wednesday it named current Chief Financial Officer Paolo De Luca as its chief strategy officer, while current board member Derrick West will join the company as CFO, effective immediately. De Luca has been CFO since December 2017. West was most recently a member of th…

Organigram posts wider-than-expected loss, weaker revenue than expected for Q4

Canadian cannabis company Organigram Holdings Inc. said Monday it had a net loss of C$22.5 million ($16.9 million), or 14 cents a share, in its fiscal fourth quarter to Aug. 31, after a profit of C$18.2 million, or 12 cents a share, in the year-earlier period. Revenue net of excise taxes came to C$…
Show more

Organigram Frequently Asked Questions

  • When was Organigram founded?

    Organigram was founded in 2013.

  • Who are Organigram key executives?

    Organigram's key executives are Gregory Engel, Amy Schwalm and Paolo de Luca.

  • How many employees does Organigram have?

    Organigram has 770 employees.

  • What is Organigram revenue?

    Latest Organigram annual revenue is C$80.4 m.

  • What is Organigram revenue per employee?

    Latest Organigram revenue per employee is C$104.4 k.

  • Who are Organigram competitors?

    Competitors of Organigram include DionyMed Holdings, Aphria and Auxly.

  • Where is Organigram headquarters?

    Organigram headquarters is located at 35 English Dr, Moncton.

  • Where are Organigram offices?

    Organigram has offices in Moncton and Toronto.

  • How many offices does Organigram have?

    Organigram has 2 offices.